Capricor

$4.30
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.21 (-4.76%) Today
+$0.10 (+2.38%) As of 8:00 PM EDT after-hours

Why Robinhood?

You can buy or sell Capricor and other stocks, options, and ETFs commission-free!

About CAPR

Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. Read More The company was founded in August 2005 and is headquartered in Beverly Hills, CA. The listed name for CAPR is Capricor Therapeutics, Inc. Common Stock.

Employees
16
Headquarters
Beverly Hills, California
Founded
2005
Market Cap
82.84M
Price-Earnings Ratio
Dividend Yield
Average Volume
429.48K
High Today
$4.44
Low Today
$4.16
Open Price
$4.44
Volume
445.04K
52 Week High
$12.32
52 Week Low
$0.88

Collections

CAPR Earnings

-$0.70
-$0.47
-$0.23
$0.00
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Estimated
per share
Actual
Expected Nov 5, After Hours

You May Also Like